SEHK:3696Life Sciences
Insilico Extends AI Drug Pipeline With New Partnership And Milestones
Insilico Medicine Cayman TopCo, ticker SEHK:3696, has entered a drug development partnership with China Medical System Holdings, focusing on central nervous system and autoimmune diseases.
The company has selected a new AI discovered preclinical candidate, adding another asset to its pipeline.
Insilico also received a milestone payment after one of its oncology compounds moved into Phase 1 studies.
Insilico Medicine operates as an AI driven drug discovery and development company, and this...